MERX Merix (MM)

Wolf Haldenstein Adler Freeman and Herz LLP Commences Class Action Lawsuit on Behalf of Merix Corporation Shareholders NEW YORK, July 9 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP filed a class action lawsuit in the United States District Court for the District of Oregon, on behalf of all persons who purchased the securities of Merix Corporation ("Merix" or the "Company") (NASDAQ:MERX) between July 1, 2003 and May 13, 2004, inclusive, (the "Class Period") against defendants Merix and certain officers of the Company. The case name is Cheng v. Merix Corporation, et al. A copy of the complaint filed in this action is available from the Court, or can be viewed on the Wolf Haldenstein Adler Freeman & Herz LLP website at http://www.whafh.com/cases/merix.htm. The complaint alleges that defendants violated the federal securities laws by issuing materially false and misleading statements throughout the Class Period that had the effect of artificially inflating the market price of the Company's securities. The complaint alleges that statements made by the defendants during the Class Period were materially false and misleading because they failed to disclose and misrepresented the following adverse facts: (i) the significant decline in the demand for the Company's premium services, which Merix was experiencing when it made its positive projections yet failed to disclose, would foreseeably result in lower profits and have a material impact on the Company's financial results; (ii) the purported demand was not being driven by strong end-user demand, but rather, the building up of inventory of Merix products by Merix' customers, especially higher-margin products, that could satisfy end-user demand, thereby jeopardizing Merix's new product sales; and (iii) as a result of the foregoing, defendants lacked a reasonable basis for their positive statements about the Company and their projections regarding the Company's financial and operational performance. If you purchased Merix securities during the Class Period, you may request that the Court appoint you as lead plaintiff by August 16, 2004. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class. Under certain circumstances, one or more class members may together serve as "lead plaintiff." Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. You may retain Wolf Haldenstein, or other counsel of your choice, to serve as your counsel in this action. Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has approximately 60 attorneys in various practice areas; and offices in Chicago, New York City, San Diego, and West Palm Beach. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation. If you wish to discuss this action or have any questions, please contact Wolf Haldenstein Adler Freeman & Herz LLP at 270 Madison Avenue, New York, New York 10016, by telephone at (800) 575-0735 (Fred Taylor Isquith, Esq., Christopher S. Hinton, Esq., George Peters, or Derek Behnke), via e-mail at or visit our website at http://www.whafh.com/. All e-mail correspondence should make reference to Merix. DATASOURCE: Wolf Haldenstein Adler Freeman & Herz LLP CONTACT: Fred Taylor Isquith, Esq., Christopher S. Hinton, Esq., George Peters, or Derek Behnke, all of Wolf Haldenstein Adler Freeman & Herz LLP, 1-800-575-0735, or Web site: http://www.whafh.com/ http://www.whafh.com/cases/merix.htm

Copyright